These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 9024376)

  • 21. Extremely rare association of HFE mutations with porphyria cutanea tarda in Japanese patients.
    Furuyama K; Kondo M; Hirata K; Fujita H; Sassa S
    Hepatology; 1999 Dec; 30(6):1532-3. PubMed ID: 10610355
    [No Abstract]   [Full Text] [Related]  

  • 22. Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda.
    Christiansen L; Bygum A; Thomsen K; Brandrup F; Hørder M; Petersen NE
    Clin Chem; 1999 Nov; 45(11):2025-6. PubMed ID: 10545080
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
    Wolff CF; Armas RM; Frank J; Poblete PG
    Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enrichment of HFE mutations in Swedish patients with familial and sporadic form of porphyria cutanea tarda.
    Harper P; Floderus Y; Holmström P; Eggertsen G; Gåfvels M
    J Intern Med; 2004 Jun; 255(6):684-8. PubMed ID: 15147533
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of the gene of hemochromatosis in first degree relatives of patient with porphyria cutanea tarda].
    García-Morillo JS; Carneado de la Fuente J; Stiefel García-Junco P; García-Donas MA; González Escribano MF; Núñez-Roldán A
    Med Clin (Barc); 1999 May; 112(18):699-701. PubMed ID: 10374203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis.
    Burt MJ; Upton JD; Morison IM; Chapman BA; Faed JM; George PM
    N Z Med J; 1997 Nov; 110(1056):429-32. PubMed ID: 9418837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients.
    Cruz-Rojo J; Fontanellas A; Morán-Jiménez MJ; Navarro-Ordóñez S; García-Bravo M; Méndez M; Muñoz-Rivero MC; de Salamanca RE
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):845-52. PubMed ID: 12699242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemochromatosis gene mutations and response to chloroquine in sporadic porphyria cutanea tarda.
    Toll A; Celis R; Ozalla MD; Ercilla MG; Herrero C
    Acta Derm Venereol; 2006; 86(3):279-80. PubMed ID: 16710604
    [No Abstract]   [Full Text] [Related]  

  • 29. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HFE gene S65C polymorphism is rare among Bulgarian porphyria cutanea tarda patients.
    von Ahsen N; Wieland E; Adjarov D; Krastev Z; Oellerich M; Ivanova A
    J Hepatol; 2001 Mar; 34(3):484-5. PubMed ID: 11322214
    [No Abstract]   [Full Text] [Related]  

  • 31. Iron status and HFE mutations in first-degree relatives of patients with sporadic porphyria cutanea tarda, in a Mediterranean area.
    Garcia-Morillo JS; Lorca RR; Bernabeu-Wittel M; Garcia-Junco PS; Andreu EP; de la Fuente JC
    J Intern Med; 2005 Apr; 257(4):389-90; author reply 391-3. PubMed ID: 15788010
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron overload in porphyria cutanea tarda.
    Sampietro M; Fiorelli G; Fargion S
    Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis.
    Rhodes DA; Raha-Chowdhury R; Cox TM; Trowsdale J
    J Med Genet; 1997 Sep; 34(9):761-4. PubMed ID: 9321765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
    Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
    Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
    An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda.
    Kushner JP; Edwards CQ; Dadone MM; Skolnick MH
    Gastroenterology; 1985 May; 88(5 Pt 1):1232-8. PubMed ID: 3979748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload.
    Fargion S; Fracanzani AL; Romano R; Cappellini MD; Faré M; Mattioli M; Piperno A; Ronchi G; Fiorelli G
    J Hepatol; 1996 May; 24(5):564-9. PubMed ID: 8773911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation.
    Macdonald GA; Tarish J; Whitehall VJ; McCann SJ; Mellick GD; Buttenshaw RL; Johnson AG; Young J; Leggett BA
    J Gastroenterol Hepatol; 1999 Dec; 14(12):1188-91. PubMed ID: 10634155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.
    Nagy Z; Kószó F; Pár A; Emri G; Horkay I; Horányi M; Karádi O; Rumi G; Morvay M; Varga V; Dobozy A; Mózsik G
    Liver Int; 2004 Feb; 24(1):16-20. PubMed ID: 15101996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.